Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.008 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |